JP2019517482A - 高カルシウム尿症及び腎結石症の治療方法及び治療用組成物 - Google Patents

高カルシウム尿症及び腎結石症の治療方法及び治療用組成物 Download PDF

Info

Publication number
JP2019517482A
JP2019517482A JP2018562172A JP2018562172A JP2019517482A JP 2019517482 A JP2019517482 A JP 2019517482A JP 2018562172 A JP2018562172 A JP 2018562172A JP 2018562172 A JP2018562172 A JP 2018562172A JP 2019517482 A JP2019517482 A JP 2019517482A
Authority
JP
Japan
Prior art keywords
vitamin
composition
container
effective amount
citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018562172A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517482A5 (enExample
Inventor
エドゥアルド アイ． カント，
エドゥアルド アイ． カント，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ana Pharmaceuticals Inc
Original Assignee
Ana Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ana Pharmaceuticals Inc filed Critical Ana Pharmaceuticals Inc
Publication of JP2019517482A publication Critical patent/JP2019517482A/ja
Publication of JP2019517482A5 publication Critical patent/JP2019517482A5/ja
Priority to JP2022124960A priority Critical patent/JP2022153651A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2018562172A 2016-06-02 2017-06-01 高カルシウム尿症及び腎結石症の治療方法及び治療用組成物 Pending JP2019517482A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022124960A JP2022153651A (ja) 2016-06-02 2022-08-04 高カルシウム尿症及び腎結石症の治療方法及び治療用組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662344653P 2016-06-02 2016-06-02
US62/344,653 2016-06-02
PCT/US2017/035514 WO2017210467A1 (en) 2016-06-02 2017-06-01 Methods and compositions for treatment of hypercalciuria and nephrolithiasis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022124960A Division JP2022153651A (ja) 2016-06-02 2022-08-04 高カルシウム尿症及び腎結石症の治療方法及び治療用組成物

Publications (2)

Publication Number Publication Date
JP2019517482A true JP2019517482A (ja) 2019-06-24
JP2019517482A5 JP2019517482A5 (enExample) 2020-07-16

Family

ID=60479095

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018562172A Pending JP2019517482A (ja) 2016-06-02 2017-06-01 高カルシウム尿症及び腎結石症の治療方法及び治療用組成物
JP2022124960A Withdrawn JP2022153651A (ja) 2016-06-02 2022-08-04 高カルシウム尿症及び腎結石症の治療方法及び治療用組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022124960A Withdrawn JP2022153651A (ja) 2016-06-02 2022-08-04 高カルシウム尿症及び腎結石症の治療方法及び治療用組成物

Country Status (14)

Country Link
US (1) US20200315233A1 (enExample)
EP (1) EP3463322A4 (enExample)
JP (2) JP2019517482A (enExample)
AU (1) AU2017274438A1 (enExample)
BR (1) BR112018075067A2 (enExample)
CA (1) CA3026143A1 (enExample)
CO (1) CO2018013999A2 (enExample)
CR (1) CR20180576A (enExample)
DO (1) DOP2018000265A (enExample)
EC (1) ECSP19000167A (enExample)
MX (2) MX2018014933A (enExample)
NI (1) NI201800126A (enExample)
TW (1) TW201808271A (enExample)
WO (1) WO2017210467A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109806225B (zh) * 2019-03-16 2021-06-01 西安安健药业有限公司 维生素k1脂肪乳注射液
CN112438967A (zh) * 2019-08-27 2021-03-05 高兵 维生素k在制备泌尿系结石防治药物和保健品中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11500709A (ja) * 1994-12-22 1999-01-19 バルツ フォルカー 副甲状腺機能亢進症処置のためのビタミンｋグループの使用
JP2013504572A (ja) * 2009-09-14 2013-02-07 ネステク ソシエテ アノニム 外因性ビタミンｋ２を含む炎症調節用栄養組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
CN1322530A (zh) * 2000-05-09 2001-11-21 詹炳炎 一种防治泌尿系结石的药物——尿石净
ES2294147T5 (es) * 2001-07-27 2011-04-04 N.V. Nutricia Composiciones enterales para la prevención y/o tratamiento de la sepsis.
AU2003237371A1 (en) * 2002-06-05 2003-12-22 Transform Pharmaceuticals, Inc. High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
US20080220094A1 (en) * 2006-11-01 2008-09-11 Wyeth Compositions and methods for the treatment and/or prevention of osteoporosis
US20100130618A1 (en) * 2007-07-24 2010-05-27 Viridis Biopharma Pvt. Ltd. Treatment of human disease conditions and disorders using vitamin k analogues and derivatives
US20110229587A1 (en) * 2009-09-24 2011-09-22 Algaecal Distribution Inc. Calcium Supplements for the Treatment of Diabetes
JP2013538799A (ja) * 2010-08-06 2013-10-17 アンペア ライフ サイエンシーズ，インコーポレイテッド ビタミンｋを用いたミトコンドリア病の処置
WO2012170773A1 (en) * 2011-06-08 2012-12-13 Edison Pharmaceuticals, Inc. Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
US20150359807A1 (en) * 2014-06-11 2015-12-17 Supernutrition Life-Extension Research, Inc. Dietary Supplement Containing Vitamin A, D3 and Vitamin K2 and Uses Thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11500709A (ja) * 1994-12-22 1999-01-19 バルツ フォルカー 副甲状腺機能亢進症処置のためのビタミンｋグループの使用
JP2013504572A (ja) * 2009-09-14 2013-02-07 ネステク ソシエテ アノニム 外因性ビタミンｋ２を含む炎症調節用栄養組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FUTUREBIOTICS VITAMIE K TRIPLE PLAY, JPN6021016047, 20 April 2021 (2021-04-20), ISSN: 0004930385 *
KIDNEY INT, vol. 83(5), JPN6021016045, 2013, pages 835 - 844, ISSN: 0004930384 *
日本内科学会雑誌, vol. 82(12), JPN6022013063, 1993, pages 12 - 16, ISSN: 0004742520 *

Also Published As

Publication number Publication date
MX2018014933A (es) 2019-04-09
TW201808271A (zh) 2018-03-16
DOP2018000265A (es) 2019-04-30
CO2018013999A2 (es) 2019-03-08
AU2017274438A1 (en) 2018-12-13
CA3026143A1 (en) 2017-12-07
MX2022013681A (es) 2022-12-13
EP3463322A1 (en) 2019-04-10
EP3463322A4 (en) 2019-11-20
NI201800126A (es) 2019-03-28
US20200315233A1 (en) 2020-10-08
BR112018075067A2 (pt) 2019-04-30
CR20180576A (es) 2019-04-09
WO2017210467A1 (en) 2017-12-07
ECSP19000167A (es) 2019-01-31
JP2022153651A (ja) 2022-10-12

Similar Documents

Publication Publication Date Title
AU775078B2 (en) Essential fatty acids in the prevention of cardiovascular events
JP2008520576A (ja) 眼性血管新生症および黄斑変性の処置に有用な組成物
JP2022153651A (ja) 高カルシウム尿症及び腎結石症の治療方法及び治療用組成物
US11026906B2 (en) Pharmaceutical quality strontium L-lactate
AU603895B2 (en) Improved flunarizine-containing compositions
JP2018150359A (ja) シトレートに富むカルシウム・マグネシウム補助剤およびその使用
RU2725743C2 (ru) Продукт на основе хелата бис-глицината железа и альгиновой кислоты и/или ее водорастворимых солей, его составы и его фармацевтические применения
KR20190041233A (ko) 황산염을 포함하는 대장 하제 조성물
KR20160133002A (ko) 신장 결석증의 치료 또는 예방을 위한 뇨 산성화제와 인산칼슘 결정화 저해제의 조합물
CN100386083C (zh) 用维生素d类化合物制备治疗骨髓发育不良综合症药物的方法
EP1171108B1 (en) Combination preparation for treating malaria
ES2729863T3 (es) Combinaciones de un agente basificante urinario y un inhibidor de cristalización del ácido úrico para el tratamiento o prevención de la litiasis renal
JP6051315B2 (ja) 乾癬を処置するためのピドチモドの使用
JP3604710B2 (ja) 骨粗鬆症予防及び治療剤
JP2003292453A (ja) 骨疾患治療用医薬複合剤
WO2012106947A1 (zh) 含维生素d和二甲双胍的药物组合物
AU2018327614B2 (en) Composition for calcium supplementation
WO2012156502A2 (en) Two component mouth rinse preparation
JP6112767B2 (ja) 血液中の尿酸値を低下させるための組成物
CN107281192A (zh) 一种减轻、治疗及预防类风湿性关节炎的组合物
WO2019048534A1 (en) COMPOSITION FOR CALCIUM SUPPLEMENTATION
JPWO2020249577A5 (enExample)
PL221337B1 (pl) Preparat do leczenia zanikowego zapalenia błony śluzowej żołądka oraz zawierająca go kapsułka
JP2005272408A (ja) 緩下剤
HK1041638B (en) Combination preparation for treating malaria

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200601

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200601

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210506

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211108

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220405

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220804

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220804

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20220816

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220921

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220926

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221128

C609 Written withdrawal of request for trial/appeal

Free format text: JAPANESE INTERMEDIATE CODE: C609

Effective date: 20230131